139 related articles for article (PubMed ID: 34581508)
1. Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma.
Wang Y; Xiao L; Zhang J; Lv X; Cao F; Zhao M; Wu F; Jing S; Wang J
Thorac Cancer; 2021 Nov; 12(22):3005-3010. PubMed ID: 34581508
[TBL] [Abstract][Full Text] [Related]
2. Incidence of brain metastasis from esophageal cancer.
Welch G; Ross HJ; Patel NP; Jaroszewski DE; Fleischer DE; Rule WG; Paripati HR; Ramirez FC; Ashman JB
Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859365
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis.
Chen Y; Wei J; Cai J; Liu A
BMC Cancer; 2019 Aug; 19(1):793. PubMed ID: 31399067
[TBL] [Abstract][Full Text] [Related]
6. Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
Chen XR; Hou X; Li DL; Sai K; Dinglin XX; Chen J; Wang N; Li MC; Wang KC; Chen LK
Clin Lung Cancer; 2021 Jan; 22(1):e25-e34. PubMed ID: 32839132
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
Sun L; Davis CW; Hwang WT; Jeffries S; Sulyok LF; Marmarelis ME; Singh AP; Berman AT; Feigenberg SJ; Levin W; Ciunci CA; Bauml JM; Cohen RB; Langer CJ; Aggarwal C
Clin Lung Cancer; 2021 Jan; 22(1):58-66.e3. PubMed ID: 33279417
[TBL] [Abstract][Full Text] [Related]
8. Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis.
Xiao L; Mowery YM; Czito BG; Wu Y; Gao G; Zhai C; Wang J; Wang J
Front Oncol; 2021; 11():652509. PubMed ID: 33996573
[TBL] [Abstract][Full Text] [Related]
9. Surgery Combined with Radiotherapy Improved Survival in Metastatic Esophageal Cancer in a Surveillance Epidemiology and End Results Population-based Study.
Wu SG; Xie WH; Zhang ZQ; Sun JY; Li FY; Lin HX; Yong Bao ; He ZY
Sci Rep; 2016 Jun; 6():28280. PubMed ID: 27323696
[TBL] [Abstract][Full Text] [Related]
10. Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery.
Li C; Shen Y; Hu F; Chu T; Yang X; Shao J; Zheng X; Xu J; Zhang H; Han B; Zhong H; Zhang X
Lung Cancer; 2020 Mar; 141():72-77. PubMed ID: 31955003
[TBL] [Abstract][Full Text] [Related]
11. The long-term survival of esophageal cancer in elderly patients: A multi-center, retrospective study from China.
Li R; He Y; Sun X; Wang N; Zhang M; Wei K; Li H; Dong P; Du L; Chen W
Cancer Med; 2023 Feb; 12(4):4852-4863. PubMed ID: 36210795
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
13. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
14. Does brain radiotherapy improve survival in patients with esophageal squamous cell carcinoma with brain metastasis?
Lin GS; Luo HC; Fu ZC; Liao SG; Cai LJ; Zhu JF
Ann Palliat Med; 2020 May; 9(3):637-643. PubMed ID: 32312072
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of head and neck cancer patients with brain metastases: A retrospective study of 88 cases.
Liu AK; Wu J; Berthelet E; Lalani N; Chau N; Tran E; Hamilton SN
Oral Oncol; 2021 Jan; 112():105086. PubMed ID: 33186892
[TBL] [Abstract][Full Text] [Related]
16. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
17. The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma.
Yin H; E M; Zhang H; Wang C
Clin Transl Oncol; 2017 Jun; 19(6):742-749. PubMed ID: 28091898
[TBL] [Abstract][Full Text] [Related]
18. A study on different therapies and prognosis-related factors for brain metastases in lung adenocarcinoma patients with driver mutation.
Yang H; He D; Wang F; Deng Q; Xie Z
Clin Exp Metastasis; 2020 Jun; 37(3):391-399. PubMed ID: 32356218
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and efficacy of concurrent chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: a respective study of 116 cases from a single institution.
Li X; Zhao LJ; Liu NB; Zhang WC; Pang QS; Wang P; Yuan ZY
Asian Pac J Cancer Prev; 2015; 16(4):1463-9. PubMed ID: 25743816
[TBL] [Abstract][Full Text] [Related]
20. Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
Arrieta O; Ramírez-Tirado LA; Caballé-Perez E; Mejia-Perez A; Zatarain-Barrón ZL; Cardona AF; Lozano-Ruíz F; Segura-González M; Cruz-Rico G; Maldonado F; Rosell R
Thorac Cancer; 2020 Apr; 11(4):1026-1037. PubMed ID: 32072746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
